NAMSA expands US footprint with Labcorp medical device testing acquisition
The deal brings Labcorp’s U.S. portfolio—including biocompatibility, microbiological, and analytical testing, as well as preclinical research—under NAMSA’s roof
The deal brings Labcorp’s U.S. portfolio—including biocompatibility, microbiological, and analytical testing, as well as preclinical research—under NAMSA’s roof
The acquisition marks a major step in PAI’s strategy to expand domestic pharmaceutical manufacturing
After leading AstraZeneca's Oncology areas nationally and internationally, Laura Colón will assume the presidency of AstraZeneca in one of its priority global markets
Collaboration funds participating biotechs to access Lilly predictive models through the Revvity Signals Xynthetica offering
The partnership builds on a prior collaboration between Nimbus and Lilly targeting AMPK in cardiometabolic diseases
Tiger Shroff fronts ‘Fit Raho, Hit Raho’ campaign
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
Pravesh brings with him over 29 years of experience in leading complex manufacturing operations and driving operational excellence
The state-of-the-art laboratory opens at the Corewell Health Southfield Center in early 2027
Syrma Johari is a globally recognised medical device engineering and manufacturing organisation
Subscribe To Our Newsletter & Stay Updated